
Hyperthyroxinemia, Familial Dysalbuminemic: Decoding Genetic Testing for a Complex Condition
A mutation in the albumin gene raises its binding affinity for T4, so identifying changes like the newly reported R222I separates FDH from hyperthyroidism.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

A mutation in the albumin gene raises its binding affinity for T4, so identifying changes like the newly reported R222I separates FDH from hyperthyroidism.

Failure of the hypothalamus to make enough GnRH delays sexual development; with anosmia it is called Kallmann syndrome. SOX10 findings are covered.

RARS1 changes disrupt protein synthesis and leave white matter short of myelin, giving developmental delay and motor impairment that worsen over time.

Hair thinning that begins in infancy and varies widely in severity defines Hypotrichosis 13; DNA testing confirms it and guides supportive treatment choices.

Autoimmune disorders, repeated infections and greater cancer susceptibility mark IMD36; DNA analysis identifies the mutation involved and informs treatment decisions.

Newborns with NISBD2 show diarrhea, skin rashes and failure to thrive, placing it among primary immunodeficiency diseases that next-generation sequencing can pinpoint.

Found before birth, a SETBP1 variant can explain IDAD29; carrier testing and counseling help families weigh options such as IVF with preimplantation diagnosis.

Because clinical signs can be subtle or mimic other conditions, ID-AD 30 is often confirmed by whole exome sequencing, which also informs care and family planning.